These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19114270)

  • 1. Eosinophil-rich inflammatory response to FloSeal hemostatic matrix presenting as postoperative pelvic pain.
    Thomas PJ; Tawfic SN
    Am J Obstet Gynecol; 2009 Apr; 200(4):e10-1. PubMed ID: 19114270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pelvic inflammatory reactions to Floseal.
    Carter RM; Halliwell B; Harkins G
    J Minim Invasive Gynecol; 2011; 18(3):284. PubMed ID: 21545954
    [No Abstract]   [Full Text] [Related]  

  • 3. Epidural spinal cord compression with neurologic deficit associated with intrapedicular application of hemostatic gelatin matrix during pedicle screw insertion.
    Buchowski JM; Bridwell KH; Lenke LG; Good CR
    Spine (Phila Pa 1976); 2009 Jun; 34(13):E473-7. PubMed ID: 19478651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery.
    Nasso G; Piancone F; Bonifazi R; Romano V; Visicchio G; De Filippo CM; Impiombato B; Fiore F; Bartolomucci F; Alessandrini F; Speziale G
    Ann Thorac Surg; 2009 Nov; 88(5):1520-6. PubMed ID: 19853105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in patients with acute anterior epistaxis.
    Mathiasen RA; Cruz RM
    Laryngoscope; 2005 May; 115(5):899-902. PubMed ID: 15867662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemostatic Thrombin-Gelatin Matrix-Related Intracranial Cyst Formation.
    Ho MY; Yang SH; Chen CM; Huang AP
    World Neurosurg; 2019 Jun; 126():475-480. PubMed ID: 30872190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemostatic matrix sealant in neurosurgery: a clinical and imaging study.
    Gazzeri R; Galarza M; Neroni M; Alfieri A; Giordano M
    Acta Neurochir (Wien); 2011 Jan; 153(1):148-54; discussion 155. PubMed ID: 20703888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of the use of novel matrix hemostatic sealant (FloSeal) to achieve hemostasis during laparoscopic excision of endometrioma.
    Angioli R; Muzii L; Montera R; Damiani P; Bellati F; Plotti F; Zullo MA; Oronzi I; Terranova C; Panici PB
    J Minim Invasive Gynecol; 2009; 16(2):153-6. PubMed ID: 19138574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Damage control management of experimental grade 5 renal injuries: further evaluation of FloSeal gelatin matrix.
    Pursifull NF; Morris MS; Harris RA; Morey AF
    J Trauma; 2006 Feb; 60(2):346-50. PubMed ID: 16508494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FloSeal hemostatic matrix in persistent epistaxis: prospective clinical trial.
    Côté D; Barber B; Diamond C; Wright E
    J Otolaryngol Head Neck Surg; 2010 Jun; 39(3):304-8. PubMed ID: 20470677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of FloSeal hemostatic matrix in a patient with severe postpartum hemorrhage.
    Lemmer R; Albrech M; Bauer G
    J Obstet Gynaecol Res; 2012 Feb; 38(2):435-7. PubMed ID: 22229547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing blood loss at myomectomy with use of a gelatin-thrombin matrix hemostatic sealant.
    Raga F; Sanz-Cortes M; Bonilla F; Casañ EM; Bonilla-Musoles F
    Fertil Steril; 2009 Jul; 92(1):356-60. PubMed ID: 19423098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative anaphylaxis to gelatin in topical hemostatic agents during anterior spinal fusion: a case report.
    Spencer HT; Hsu JT; McDonald DR; Karlin LI
    Spine J; 2012 Aug; 12(8):e1-6. PubMed ID: 23021035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Haemorrhagic complications in thyroid surgery. Control of bleeding from retroneural vessels using collagen and thrombin gelatine granules].
    Tonante A; Lo Schiavo MG; Bonanno L; D'Alia C; Taranto F; Gagliano E; Sturniolo G
    Chir Ital; 2006; 58(1):61-8. PubMed ID: 16729611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytologic findings following intraoperative use of Floseal
    Barroeta JE; Lhospital E; Smith E; Ko EM
    Diagn Cytopathol; 2016 Dec; 44(12):1117-1119. PubMed ID: 27535119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemostatic agent microporous polysaccharide hemospheres (MPH) does not affect healing or intact sinus mucosa.
    Antisdel JL; Janney CG; Long JP; Sindwani R
    Laryngoscope; 2008 Jul; 118(7):1265-9. PubMed ID: 18438268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retained surgical sponge presenting as chronic pelvic pain.
    Nieves L; Schnatz PF; Sahakyan M; Sorosky JI
    Conn Med; 2007 Sep; 71(8):461-3. PubMed ID: 17902383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gelatin matrix treatment of complex renal injuries in a porcine model.
    Hick EJ; Morey AF; Harris RA; Morris MS
    J Urol; 2005 May; 173(5):1801-4. PubMed ID: 15821591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small bowel obstruction after FloSeal use.
    Clapp B; Santillan A
    JSLS; 2011; 15(3):361-4. PubMed ID: 21985725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative safety and efficacy of topical hemostatic agents in a rat neurosurgical model.
    Ereth MH; Schaff M; Ericson EF; Wetjen NM; Nuttall GA; Oliver WC
    Neurosurgery; 2008 Oct; 63(4 Suppl 2):369-72; discussion 372. PubMed ID: 18981845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.